Navigation Links
Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
Date:6/26/2012

New York City, NY (PRWEB) June 26, 2012

The Actos Resource Center, a patient advocacy group, is alerting patients who suffered injury after taking the diabetes drug Actos that certain Statutes of Limitation in their state could limit the amount of time they have to file a claim.

Anyone who has been diagnosed with bladder cancer or heart disease after taking the drug should consult with their doctor and contact a lawyer to learn about their legal options.

A little over a year ago on June 15, 2011, the FDA warned that Actos may be associated with a higher risk of bladder cancer. According to The Canadian Press on April 19, 2012, Health Canada joined the U.S., France, Germany and the European Medicines Agency in also issuing an Actos bladder cancer warning.

Hundreds of people have now contacted the Actos Resource Center to learn about their legal options after suffering bladder cancer, heart attacks or liver damage.

According to a Bloomberg report, Takeda faces thousands of Actos lawsuits from patients in the U.S. In an article published March 13, 2012, the news agency predicted as many as 10,000 patients may eventually file an Actos bladder cancer lawsuit.

However, victims who were prescribed Actos in a state with a one-year statute of limitations could face added legal challenges. According to lawyers with the Actos Resource Center, attorneys for Takeda Pharmaceuticals will likely argue that the deadline for victims in these states started on June 15, 2011 with the FDA warning and should expire a year later.

So far, no court has indicated that such cases would be barred, and a qualified lawyer can advise how long victims have to take action. However, since each case has a different expiration date, anyone affected is urged to seek help as soon as possible.

In December, a federal Judicial Panel on Multidistrict Litigation issued an order consolidating all lawsuits to a federal court in Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette)

The Actos Bladder Cancer Center only works with Actos lawyers who are actively involved in this litigation and have handled thousands of cases.

For more information on the research, actos warnings, side effects and legal options relating to the drug Actos, or to speak with a lawyer, visit http://www.ActosCancer.com.

Read the full story at http://www.prweb.com/releases/actos-bladder/cancer-lawsuit/prweb9640081.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Candeo Partners with Catholic Church Organization to Release New Sexual Addiction Recovery Program
2. Brain-Injury Recovery Varies Widely Among Children
3. Substance Abusers, Even Recovering Ones, May Face Stigma
4. Recovery from propofol anesthesia may be sped by use of common stimulant
5. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
6. Surgical sling reduces risk of weakened bladder control after prolapse surgery, U-M study says
7. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
8. Study Ties Secondhand Smoke to Bladder Irritation in Kids
9. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
10. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
11. Chemo + Radiation Best for Bladder Cancer, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... Room (ER) on Wednesday, August 16, to community partners. The newly renovated ER ... “Fast Track” area for minor emergencies, eight semi-private rooms to deliver patient results, ...
(Date:8/17/2017)... ... 17, 2017 , ... An August 2 article on NextShark discusses ... largely influenced by the growing popularity of “pretty boys” in both K-Pop and television ... of male appearance are changing not only in the Asian nation, where plastic surgery ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC ... Parks is a member of the firm’s Commercial Litigation and Employment Law groups. , ... wealth of knowledge in matters of employment litigation, commercial litigation and business disputes. Her ...
(Date:8/17/2017)... ... 2017 , ... Finalists in the 2017 (second annual) ... awards recognize the world’s best employers and the human resources professionals, teams, achievements ... to work. , A diverse group of organizations and individuals around the world ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... Insightin Health, provider of data-driven decision-making ... announced the selection of Michael Wood ... as of February 2017. In this role, Wood will ... our clients. Wood brings with him more than ... analytics within the healthcare industry. Wood formerly served ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: